Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Disseminated malignant phaeochromocytoma: localisation with iodine-131-labelled meta-iodobenzylguanidine.

Literature DB >> 6812783

Disseminated malignant phaeochromocytoma: localisation with iodine-131-labelled meta-iodobenzylguanidine.

H Sutton, P Wyeth, A P Allen, O A Thurtle, T K Hames, M I Cawley, D Ackery.

Abstract

Meta-iodobenzylguanidine, a guanethidine analogue, is a newly synthesised substance capable of imaging the adrenal medulla. In a woman in whom phaeochromocytoma has been diagnosed iodine-131-labelled metaiodobenzylguanidine was given intravenously; gamma-camera images showed bilateral adrenal tumours and uptake corresponding to bone and liver metastases. 131I-meta-iodobenzylguanidine is effective in localising phaeochromocytomas, and the technique is safe, specific, and non-invasive.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1982 PMID： 6812783 PMCID： PMC1500117 DOI： 10.1136/bmj.285.6349.1153

Source DB: PubMed Journal: Br Med J (Clin Res Ed) ISSN： 0267-0623

4 in total

1. New horizons for therapeutic nuclear medicine in 1981.

Authors: W H Beierwaltes
Journal: J Nucl Med Date: 1981-06 Impact factor: 10.057

2. Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.

Authors: D M Wieland; J Wu; L E Brown; T J Mangner; D P Swanson; W H Beierwaltes
Journal: J Nucl Med Date: 1980-04 Impact factor: 10.057

3. Scintigraphic localization of pheochromocytoma.

Authors: J C Sisson; M S Frager; T W Valk; M D Gross; D P Swanson; D M Wieland; M C Tobes; W H Beierwaltes; N W Thompson
Journal: N Engl J Med Date: 1981-07-02 Impact factor: 91.245

4. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series.

Authors: M G Sutton; S G Sheps; J T Lie
Journal: Mayo Clin Proc Date: 1981-06 Impact factor: 7.616

4 in total

7 in total

Review 1. Diagnostic problems in pheochromocytoma.

Authors: M Mannelli
Journal: J Endocrinol Invest Date: 1989-11 Impact factor: 4.256

2. Intractable constipation in malignant phaeochromocytoma: combined treatment with adrenergic blockade and cholinergic drugs.

Authors: O A Thurtle; A P Allen; M T Walters; J V Kitchen; C L Smith; M I Cawley
Journal: J R Soc Med Date: 1984-04 Impact factor: 5.344

3. Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine.

Authors: L Troncone; C L Maini; G De Rosa; S M Corsello; V Rufini; O Mattei; N Bonifazi
Journal: Eur J Nucl Med Date: 1984

Disseminated malignant phaeochromocytoma: localisation with iodine-131-labelled meta-iodobenzylguanidine.

1. New horizons for therapeutic nuclear medicine in 1981.

2. Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine.

3. Scintigraphic localization of pheochromocytoma.

4. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series.

Review 1. Diagnostic problems in pheochromocytoma.

2. Intractable constipation in malignant phaeochromocytoma: combined treatment with adrenergic blockade and cholinergic drugs.

3. Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine.

4. New approach to the localisation of phaeochromocytoma: imaging with iodine-131-meta-iodobenzylguanidine.

5. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

6. Role of venous sampling in locating a phaeochromocytoma.

7. Implications and considerations during pheochromocytoma resection: A challenge to the anesthesiologist.